3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
5
Neoplasms
3
Colorectal Neoplasms
3
Multiple Myeloma
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Myeloid
1
Sarcoma
1
Rhabdoid Tumor
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Polycythemia Vera
1
Parkinsonian Disorders
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Histiocytoma, Malignant Fibrous
1
High Grade Neuroendocrine Neoplasms
1
Interventions
prexasertib
1
Zoledronic Acid
1
Tamoxifen
1
Docetaxel
1
Carboplatin
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Hereditary Breast and Ovarian Cancer Syndrome
×
Blood Specimen Collection
×
Clear all
NCT01333748
2012-07-13
EXSAL
Centre Francois Baclesse
Phase 2
Completed
530 enrolled